Dynamic Technology Lab Private Ltd Makes New $559,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Dynamic Technology Lab Private Ltd purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,139 shares of the medical equipment provider's stock, valued at approximately $559,000.

Several other large investors have also recently modified their holdings of ISRG. Fisher Asset Management LLC grew its stake in Intuitive Surgical by 1.8% during the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock worth $2,349,441,000 after buying an additional 86,208 shares during the last quarter. Daiwa Securities Group Inc. grew its stake in shares of Intuitive Surgical by 13.5% during the third quarter. Daiwa Securities Group Inc. now owns 86,257 shares of the medical equipment provider's stock worth $42,375,000 after acquiring an additional 10,267 shares during the last quarter. Marco Investment Management LLC acquired a new position in shares of Intuitive Surgical during the third quarter valued at about $264,000. Summit Trail Advisors LLC raised its position in shares of Intuitive Surgical by 15.7% in the 3rd quarter. Summit Trail Advisors LLC now owns 5,452 shares of the medical equipment provider's stock valued at $2,678,000 after purchasing an additional 738 shares during the last quarter. Finally, Draper Asset Management LLC boosted its stake in Intuitive Surgical by 39.1% in the 3rd quarter. Draper Asset Management LLC now owns 1,565 shares of the medical equipment provider's stock worth $769,000 after purchasing an additional 440 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

A number of research analysts have issued reports on ISRG shares. Piper Sandler reaffirmed an "overweight" rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an "outperform" rating in a report on Friday, October 18th. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Leerink Partners raised their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $526.06.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $3.45 during trading hours on Friday, reaching $542.00. The company's stock had a trading volume of 718,571 shares, compared to its average volume of 1,452,211. The firm has a market capitalization of $193.05 billion, a price-to-earnings ratio of 87.14, a P/E/G ratio of 5.30 and a beta of 1.39. The company's 50-day moving average is $510.03 and its two-hundred day moving average is $469.00. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $552.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 2,128 shares of the business's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. The trade was a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jamie Samath sold 269 shares of the firm's stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. The trade was a 2.98 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 50,459 shares of company stock worth $26,080,251. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.